Abstract
Over the last century, microorganisms have been a great source of metabolic and enzymatic diversity. In recent years, emerging recombinant DNA techniques have facilitated the development of new efficient expression systems, modification of biosynthesis pathways leading to different metabolites by metabolic engineering, and enhancement of catalytic properties of enzymes by directed evolution. More exciting advances are still to come as the complete sequencing of industrially important microbial genomes takes place. Functional genomics and proteomics are already major tools used in the search for new molecules and development of higher-producing strains.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Tani Y., Lim W. J., and Yang, H. C. (1988) Isolation of L-methionine-enriched mutant ofa methylotrophic yeast, Candidi boidinii No. 2201. J. Ferm. Technol. 66, 153–158.
Nelis H. J. and De Leenheer, A. P. (1991) Microbial sources of carotenoid pigments usedin foods and feeds. J. Appl. Bacteriol. 70, 181–191.
Torget R., Kim J., and Lee, Y. Y. (2000) Fundamental aspects of dilute acidhydrolysis/fractionation kinetics of hardwood carbohydrates. 1. Cellulose hydrolysis. Ind.Eng. Chem. Res. 39, 2817–2825.
Demain A. L. (2000) Microbial biotechnology. Trends Biotechnol. 18, 26–31.
Demain, A. L. (1996) Fungal secondary metabolism: regulation and functions, in ACentury of Mycology (Sutton, B., ed.), Cambridge University Press, Cambridge, MA, pp.233–254.
Strohl, W. R. (1997) Industrial antibiotics: today and the future, in Biotechnology ofAntibiotics, 2nd ed. (Strohl, W. R., ed.), Marcel Dekker, New York, pp. 1–47.
Brown, A. G.,T. C., King T. 1, Hasenkamp R., and Thompson, R. H. (1976)Crystal and molecular structure of compactin: a new antifungal metabolite from Penicillium brevicompactum.J. Chem. Soc. Perkin Trans I, 1165–1170.
Endo A., Kuroda M., and Tsujita, Y. (1976) ML-236B and ML-236C, new inhibitors ofcholesterolgenesis produced by Penicillium citrinin. J. Antibiot. 29, 1346–1348.
Endo, A. (1979) K Monacolin, a new hypocholesterolemic agent produced by Monascusspecies. J. Antibiot. 32, 852–854.
Alberts A. W., Chen J., Kuron G., Hunt V., Huff J., Hoffman, C., et al. (1980)Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme Areductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA 77, 3957–3961.
Wall, M. E. and Wani, M. C. (1995) Campothecin and Taxol: discovery to clinic. CancerRes. 55, 753–760.
Stierle A., Strobel G., and Stierle, D. (1993) Taxol and taxane production by Taxomycesandreanae, an endophytic fungus of Pacific yew. Science 260, 214–216.
Yamada H., Shimizu S., and Kobayashi, M. (2001) Hydratases involved in nitrile conversion:screening, characterization and application. Chem. Rec. 1, 152–161.
Thomas S. M., DiCosimo R., and Nagarajan, V. (2002) Biocatalysis: applications andpotentials for the chemical industry. Trends Biotechnol. 20, 238–242.
Stroh, W. H. (1998) Industrial enzymes market. Gen. Eng. News 18, 11–38.
Rao M. B., Tanksale A. M., Ghatge M. S., and Deshpande, V. V. (1998) Molecular andbiotechnological aspects of microbial proteases. Microbiol. Mol. Biol. Rev. 62, 597–635.
Tzanov T., Calafell M., Guebitz G. M., and Cavaco-Paulo, A. (2001) Bio-preparation ofcotton fabrics. Enzyme Microb. Technol. 29, 357–362.
Farrell R. L., Hata K., and Wall, M. B. (1997) Solving pitch problems in pulp and paperprocesses by the use of enzymes or fungi. Adv. Biochem. Eng. Biotechnol. 57, 197–212.
Koeller K. M. and Wong, C. H. (2001) Enzymes for chemical synthesis. Nature 409,232–240.
Klibanov, A. (2001) Improving enzymes by using them in organic solvents. Nature 409,241–246.
Kirchner G., Scollar M. P., and Klibanov, A. (1995) Resolution of racemic mixtures vialipase catalysis in organic solvents. J. Am. Chem. Soc. 107, 7072–7076.
Zaks A. and Dodds, D. R. (1997) Application of biocatalysis and biotransformations tothe synthesis of pharmaceuticals. Drug Disc. Today 2, 513–531.
Carrea G. and Riva, S. (2000) Properties and synthetic applications of enzymes in organicsolvents. Angew. Chem. 33, 2226–2254.
Lee M. Y. and Dordick, J. S. (2002) Enzyme activation for nonaqueous media. Curr.Opin. Biotechnol. 13, 376–384.
Kirk O., Borchert T. V., and Fulgsang, C. C. (2002) Industrial enzyme applications. Curr.Opin. Biotechnol. 13,345–351.
Swartz, J. R. (1996) Escherichia coli recombinant DNA technology, in Escherichia coliand Salmonella: Cellular and Molecular Biology, 2nd ed. (Neidhardt, F. C., ed.)American Society of Microbiology Press, Washington, DC, pp. 1693–1771.
He X. S., Shyu Y. T., Nathoo S., Wong S. L., and Doi, R. H. (1991) Construction anduse of a Bacillus subtilis mutant deficient in multiple protease genes for the expression ofeukaryotic genes. Ann. NY Acad. Sci. 646, 69–77.
Romanos M. A., Scorer C. A., and Clare, J. J. (1992) Foreign gene expression in yeast: areview. Yeast 8,423–4188.
Higgins D. R. and Cregg, J. M. (1998) Introduction to Pichia pastoris, in PichiaProtocols (Higgins D. R. and Cregg, J. M., eds.), Humana Press, Totowa, NJ, pp. 1–15.
Bretthauer R. K. and Castellino, R J. (1999) Glycosylation of Pichia pastoris-derivedproteins. Biotechnol. Appl. Biochem. 30, 193–200.
Romanos M. A. (1995) Advances in the use of Pichia pastoris for high-level expression.Curr. Opin. Biotechnol. 6, 527–533.
Sohn J. H., Kang H. A., Rao K. J., Kim C. H., Choi E. S., Chung B. H., and Rhee S.K. (2001) Current status of the anticoagulant hirudin: its biotechnological production andclinical practice. Appl. Microbiol. Biotechnol. 57, 606–613.
Giuseppin M., van Eijk H. M., and Bes B. C. (1988) Molecular regulation of methanoloxidase activity in continuous cultures of Hansenula polymorpha. Biotechnol. Bioeng. 32,577–583.
Egli T., van Dijken J. P., Veenhuis M., Harder W., and Feichter, A. (1980) Methanolmetabolism in yeasts: regulation of the synthesis of catabolite enzymes. Arch. Microbiol. 124,115–121.
Shuster J. R. and Connelley M. B. (1999) Promoter-tagged restriction enzyme-mediatedinsertion mutagenesis in Aspergillus niger. Mol. Gen. Genet. 262, 27–34.
Gouka R. J., Gerk C., Hooykaas P. J. J., Bundock P., Musters W., Verrips C. T., and deGroot M. J. A. 1999) Transformation of Aspergillus awamori by Agrobacterium tumefa-ciens-mediated homologous recombination. Nat. Biotechnol. 6, 598–601.
van de Hombergh, J. P. van de Vondervoort, P. J., van der Heijden, N. C., and Visser, J.(1997) New protease mutants in Aspergillus niger result in strongly reduced in vitrodegradation of target proteins; genetical and biochemical characterization of seven complementationgroups. Curr. Genet. 28, 299–308.
Gouka R. J., Punt P. J., and van den Hondel, C. A. M. J. J. (1997) Efficient production ofsecreted proteins by Aspergillus: progress, limitations and prospects. Appl. Microbiol.Biotechnol. 47, 1–11.
Moralejo E J., Cardoza R. E., Gutierrez S., and MartÍn, J. F. (1999) Thaumatin productionin Aspergillus awamori by use of expression cassettes with strong fungal promotersand high gene dosage. Appl. Environ. Microbiol. 65, 1168–1174.
Ward P., Cunningham G. A., and Conneelly O. M. (1997) Commercial production oflactoferrin, a multifunctional iron-binding glycoprotein. Biotechnol. Genet. Eng. Rev. 14,303–319.
Dunn-Coleman N. S., Bloebaum P., Berka R., Bodie E., Robinson N., Armstrong G.,et al. (1991) Commercial levels of chymosin production by Aspergillus. Bio/Technology 9,976–981.
Datamonitor. (2000) Therapeutic Proteins, Key Markets and Future Strategies. Referencecode DMHC1552, Datamonitor Publications, New York, NY, p. 33.
Green B. A. and Baker, S. M. (2002) Recent advances and novel strategies in vaccinedevelopment. Curr. Opin. Microbiol. 5, 483–488.
Brown, K. S. (1996) Looking back at Jenner, vaccine developers prepare for 21st century.The Scientist 10 (April 1), 14,17.
Pramik, M. J. (1999) Recombinant human growth hormone. Gen. Eng. News 19(1),15,27,32,33.
Stephanopoulos G., Aristodou A., and Nielsen, J. (eds.) (1998) Metabolic Engineering. Academic, San Diego, CA.
Ostergaard S., Olsson L., and Nielsen, J. (2000) Metabolic engineering ofSaccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 64, 34–50.
Rohlin L., Oh, M. K., and Liao J. C. (2001) Microbial pathway engineering for industrialprocesses: evolution, combinatorial biosynthesis and rational design. Curr. Opin.Microbiol. 4, 350–355.
Bongaerts J., Kramer M., Muller U., Raeven L., and Wubbolts M. (2001) Metabolicengineering for microbial production of aromatic amino acids and derived compounds.Metab. Eng. 3, 289–300.
Mielenz J. R. (2001) Ethanol production from biomass: technology and commercializationstatus. Curr. Opin. Microbiol. 4, 324–329.
Ingram L. O., Conway T., Clark D. P., Sewell G. W., and Preston, J. R (1987) Geneticengineering of ethanol production in Escherichia coli. Appl. Environ. Microbiol. 53,2420–2425.
Lynd, L. (1996) Overview and evaluation of fuel ethanol from cellulosic biomass: technology,economics and policy. Ann. Rev. Energy Environ. 21, 403–465.
Eggeling L. and Sahm H. (1999) Amino acid production: principles of metabolic engineering,in Metabolic Engineering (Lee S. Y. and Papoutsakis, E. T., eds.), MarcelDekker, New York, pp. 153–176.
Shibasaki T., Hashimoto S., Mori H., and Ozaki, A. (2000) Construction of a novelhydroxyproline-producing recombinant Escherichia coli by introducing a proline 4-hydroxylase gene. J. Biosci. Bioeng. 90, 522–525.
Weikert C., Sauer U., and Bailey, J. E. (1998) Increased phenylalanine production bygrowing and nongrowing Escherichia coli strain CWML2. Biotechnol. Prog. 14, 420–424.
Ikeda M. and Katsumata, R. (1999) Hyperproduction of tryptophan by Corynebacteriumglutamicum with the modified pentose phosphate pathway. Appl. Environ. Microbiol. 65,2497–2502.
Levy-Schil S., Debussche L., Rigault S., Soubrier F., Bacchette F., Lagneaux D., et al.(1993) Biotin biosyntheric pathway in a recombinant strain of Escherichia coli overex-pressingbio genes: evidence for a limiting step upstream from KAPA. Appl. Microbiol.Biotechnol. 38, 755–762.
Sakurai N., Imai Y., Masuda M., Komatsubara S., and Tosa T. (1994) Improvement of a d-biotin-hyperproducingrecombinant strain of Serratia marcescens. J. Biotechnol. 36, 63–73.
Masuda M., Takahashi K., Sakurai N., Yanagiya K., Komatsubara S., and Tosa T.(1995) Further improvement of D-biotin production by a recombinant strain of Serratiamarcescens. Proc. Biochem. 30, 553–562.
Saito Y., Ishii Y., Hayashi H., Imao Y., Akashi T., Yoshikawa K., et al. (1997) Cloningof genes coding for L-sorbose and L-sorbosone dehydrogenases from Gluconobacter oxy-dansand microbial production of 2-keto-L-gulonate, a precursor of L-ascorbic acid, in arecombinant Gluconobacter oxydans strain. Appl. Environ. Microbiol. 63,454–460.
Shibata T., Ichikawa C., Matsuura M., Takata Y., Noguchi Y., Saito Y., and Yamashita, M. (2000) Cloning of a gene for D-sorbitol dehydrogenase from Gluconobacter oxydansG624 and expression of the gene in Pseudomonas putida IFO3738. J. Biosci. Bioeng. 89,463–468.
Koizumi S., Yonetani Y., Maruyama A., and Teshiba, S. (2000) Production of riboflavinby metabolically engineered Corynebacterium ammoniagenes. Appl. Microbiol.Biotechnol. 51, 674–679.
Perkins J. B., Sloma A., Hermann T., Theriault K., Zachgo E., Erdenberger, T., et al.(1999) Genetic engineering of Bacillus subtilis for the commercial production ofriboflavin. J. Ind. Microbiol. Biotechnol. 22, 8–18.
Chen C. W., Lin H. R, Kuo C. L., Tsai H. L., and Tsai J. R Y. (1988) Cloning and expressionof a DNA sequence conferring cephamycin C production. Bio/Technology 6,1222–1224.
Decker H., Summers R. G., and Hutchinson, C. R. (1994) Overproduction of the acylcarrier protein component of a type II polyketide synthase stimulates production of tetra-cenomycinbiosynthetic intermediates in Streptomyces glaucescens. J. Antibiot. 47, 54–63.
Malmberg L.-H., Hu W.-S., and Sherman D. H. (1995) Effects of enhanced lysine ε-aminotransferaseon cephamycin biosynthesis in Streptomyces clavuligerus. Appl.Microbiol. Biotechnol. 44, 198–205.
Kennedy J. and Turner, G. (1996) δ-L-α-aminoadipyl-L-cysteinyl-D-valine synthetase isa rate limiting enzyme for penicillin production in Aspergillus nidulans. Mol. Gen. Genet.253, 189–197.
Crawford L., Stepan A. M., McAda P. C., Rambosek J. A., Conder M. J., Vinci V. A.,and Reeves C. D. (1995) Production of cephalosporin intermediates by feeding adipicacid to recombinant Penicillium chrysogenum strains expressing ring expansion activity.Bio/Technology 13, 58–62.
Velasco J., Adrio J. L., Moreno M. A., Diez B., Soler G., and Barredo J. L. (2000)Environmentally safe production of 7-aminodeacetoxycephalosporanic acid (7-ADCA)using recombinant strains of Acremonium chrysogenum. Nat. Biotechnol. 18, 857–861.
Rodriguez E. and McDaniel, R. (2001) Combinatorial biosynthesis of antimicrobials andother natural products. Curr. Opin. Microbiol. 4, 526–534.
Mendez C. and Salas, J. A. (2001) Altering the glycosylation pattern of bioactive compounds.Trends Biotechnol. 19, 449–456.
Okanishi M., Suzuki N., and Furita, T. (1996) Variety of hybrid characters amongrecombinants obtained by interspecific protoplast fusion in streptomycetes. Biosci.Biotech. Biochem. 6, 1233–1238.
Bodie E. A., Armstrong G. L., and Dunn-Coleman, N. S. (1994) Strain improvement ofchymosin-producing strains of Aspergillus nigervar awamori using parasexual recombination.Enzyme Microb. Tech. 16, 376–382.
Pariza M. W. and Johnson, E. A. (2001) Evaluating the safety of microbial enzyme preparationsused in food processing: update for a new century. Regul. Toxicol. Pharmacol. 33,173–186.
Kirk O., Borchert T. V., and Fuglsang, C. C. (2002) Industrial enzyme applications. Curr.Opin. Biotechnol. 13,345–351.
Rondon M. R., Goodman R. M., and Handelsman, J. (1999) The earth’s bounty: assessingand accessing soil microbial diversity. Trends Biotechnol. 17,403–409.
Schiraldini C. and De Rosa, M. (2002) The production of biocatalysts and biomoleculesfrom extremophiles. Trends Biotechnol. 20, 515–521.
Marrs B., Delagrave S., and Murphy, D. (1999) Novel approaches for discovering industrialenzymes. Curr. Opin. Microbiol. 2, 241–245.
Schmid A., Dordick J. S., Hauer B., Kiener A., Wubbolts M., and Witholt, B. (2001)Industrial biocatalysis today and tomorrow. Nature 409, 258–268.
Cedrone F., Menez A., and Quemeneur, E. (2000) Tailoring new enzyme functions byrational redesign. Curr. Opin. Struct. Biol. 10, 405–410.
Beppu, T. (1990) Modification of milk-clotting aspartic proteinases by recombinant DNAtechniques. Ann. NYAcad. Sci. 613, 14–25.
Van den Burg B., de Kreij A., Van der Veek P., Mansfeld J., and Venema G. (1998)Engineering an enzyme to resist boiling. Proc. Natl. Acad. Sci. USA 95, 2056–2060.
Bolon D. N., Voigt C. A., and Mayo S. L. (2002) De novo design of biocatalysts. Curr.Opin. Struct. Biol. 6, 125–129.
Shimaoka M., Shiftman J. M., Jing H., Tagaki J., Mayo S. L., and Springer T. A.(2000) Computational design of an integrin I domain stabilized in the open high affinityconformation. Nat. Struct. Biol. 7, 674–678.
Arnold R H. (2001) Combinatorial and computational challenges for biocatalyst design.Nature 409, 253–257.
Leung D. W., Chen E., and Goeddel D. V. (1989) A method for random mutagenesis ofa defined DNA segment using a modified polymerase chain reaction. Technique 1, 11–15.
Reidhaar-Olson J., Bowie J., Breyer R. M., Hu J. C., Knight K. L., Lim W. A., et al.(1991) Random mutagenesis of protein sequences using oligonucleotide cassettes.Methods Enzymol. 208, 564–586.
Bornscheuer U. T., Altenbuchner J., and Meyer, H. H. (1998) Directed evolution of anesterase for the stereoselective resolution of a key intermediate in the synthesis of epith-ilones. Biotechnol. Bioeng. 58, 554–559.
Taguchi S., Ozaki A., and Momose, H. (1998) Engineering of a cold-adapted protease bysequential random mutagenesis and a screening system. Appl. Environ. Microbiol. 64,492–495.
Ness J. E., Del Cardayre S. B., Minshull J., and Stemmer W. P. (2000) Molecularbreeding: the natural approach to protein design. Adv. Protein Chem. 55, 261–292.
Stemmer W. P. (1994) Rapid evolution of a protein in vitro by DNA shuffling. Nature 370,389–391.
Zhao H. and Arnold, E H. (1997) Optimization of DNA shuffling for high fidelity recombination.Nucleic Acids Res. 25, 1307–1308.
Crameri A., Raillard S. A., Bermudez E., and Stemmer W. P. (1998) DNA shuffling of afamily of genes from diverse species accelerates directed evolution. Nature 391, 288–291.
Kurtzman A. L., Govindarajan S., Vahle K., Jones J. T., Heinrichs V., and Patten, P. A.(2001) Advances in directed protein evolution by recursive genetic recombination: applicationsto therapeutic proteins. Curr. Opin. Biotechnol. 12, 361–370.
Lutz S., Ostermeier M., Moore G. L., Maranas C. D., and Benkovic S. P. (2001)Creating multiple-crossover DNA libraries independent of sequence identity. Proc. Natl.Acad. Sci. USA 98, 11,248–11,253.
Ness J. E., Welch M., Giver L., Bueno M., Cherry J. R., Borchert T. V., et al. (1999)DNA shuffling of subgenomic sequences of subtilisin. Nat. Biotechnol. 17, 893–896.
Jaeger K. E. and Reetz, M. T. (2000) Directed evolution of enantioselective enzymes fororganic chemistry. Curr. Opin. Chem. Biol. 4, 68–73.
Suenaga H., Mitsokua M., Ura Y., Watanabe T., and Furukawa, K. (2001) Directed evolutionof biphenyl dioxygenase: emergence of enhanced degradation capacity for benzene,toluene, and alkylbenzenes. J. Bacteriol. 183, 5441–5444.
Song J. K. and Rhee, J. S. (2001) Enhancement of stability and activity of phospholipaseA(1) in organic solvents by directed evolution. Biochim. Biophys. Acta 1547, 370–378.
Raillard S., Krebber A., Chen Y., Ness J. E., Bermudez E., Trinidad R., et al. (2001)Novel enzyme activities and functional plasticity revealed by recombining highly homologousenzymes. Chem. Biol. 8, 891–898.
Patten P. A., Howard R. J., and Stemmer W. P. (1997) Applications of DNA shuffling topharmaceuticals and vaccines. Curr. Opin. Biotechnol. 8, 724–733.
Tobin M. B., Gustafsson C., and Huisman, G. W. (2000) Directed evolution: the “rational”basis for “irrational” design. Curr. Opin. Struct. Biol. 10, 421–427.
Zhang Y. X., Perry K., Vinci V. A., Powell K., Stemmer W. P., and del Cardayre, S. B.(2002) Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature 415,644–646.
Patnaik R., Louie S., Gavrilovic V., Perry K., Stemmer W. P., Ryan C. M., and delCardayre S. B. (2002) Genome shuffling of Lactobacillus for improved acid tolerance.Nat. Biotechnol. 20, 707–712.
Tong I.-T., Liao J. J., and Cameron D. C. (1991) 1,3-Propane diol production byEscherichia coli expressing genes from the Klebsiella pneumoniae dha region. Appl.Environ. Microbiol. 57, 3541–3546.
Laffend L. A., Nagarajan V., and Nakamura C. E. (1996) Bioconversion of a fermentablecarbon source to 1,3-propanediol by a single microorganism. Patent WO96/53.796 (E. I. DuPont de Nemours and Genencor International).
Picataggio S., Rohrer T., Deanda K., Lanning D., Reynolds R., Mielenz J., and Eirich, L. D. (1992) Metabolic engineering of Candida tropicalis for the production of long-chaindicarboxylic acids. Bio/Technology 10, 894–898.
Arisawa A., Kawamura N., Narita T., Kojima I., Okamura K., Tsunekawa, H., et al.(1996) Direct fermentative production of acyltylosins by genetically-engineered strains ofStreptomyces fradiae. J. Antibiot. 49, 349–354.
National Academy of Sciences U.S.A. (2000) Transgenic Plants and World Agriculture,National Academy Press, Washington, DC.
Fox, S. (2000) Golden rice intended for developing world. Gen. Eng. News 20(12), 42,50.
Bigelas, R. (1989) Industrial products of biotechnology: Application of gene technology,in Biotechnology, vol. 7b (Rehm H. J. and Reed, G. eds.; Jacobson G. K. and Jolly, S.O., vol. eds.) VCH, Weinheim, Germany, pp. 229–259.
Tseng Y. H., Ting W. Y., Chou H. C., Yang B. Y., and Chun, C. C. (1992) Increase ofxanthan production by cloning xps genes into wild-type Xanthomonas campestris. Lett.Appl. Microbiol. 14, 43–46.
Letisse F., Chevallereau P., Simon J.-L., and Lindley N. D. (2001) Kinetic analysis ofgrowth and xanthan gum production with Xanthomonas campestris on sucrose, usingsequentially consumed nitrogen sources. Appl. Microbiol. Biotechnol. 55, 417–422.
Potera, C. (1997) Genencor & DuPont create “green” polyester. Gen. Eng. News 17(11), 17.
Akkara J. A., Ayyagari M. S., and Bruno, F. F. (1999) Enzymatic synthesis and modificationof polymers in nonaqueous solvents. Trends Biotechnol. 17, 67–73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Adrio, J.L., Demain, A.L. (2005). Microbial Cells and Enzymes A Century of Progress. In: Barredo, J.L. (eds) Microbial Enzymes and Biotransformations. Methods in Biotechnology, vol 17. Humana Press. https://doi.org/10.1385/1-59259-846-3:001
Download citation
DOI: https://doi.org/10.1385/1-59259-846-3:001
Publisher Name: Humana Press
Print ISBN: 978-1-58829-253-7
Online ISBN: 978-1-59259-846-5
eBook Packages: Springer Protocols